Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
A major workforce optimisation programme has started at the Countess of Chester Hospital NHS Foundation Trust in partnership with workforce planning specialists, SARD.
Read more here.
Nursing education is really no longer limited to textbooks and clinical rotations. The accelerated embrace of digital technologies is transforming the way future nurses learn, with education becoming more accessible, flexible and interactive. Technology, ranging from AI-powered tutoring systems to…